Table 1 Patient demographics
From: Motion correction and its impact on quantification in dynamic total-body 18F-fluorodeoxyglucose PET
Subject (lesion) | Gender | Age | Height (cm) | Weight (kg) | Injection dose (MBq) |
|---|---|---|---|---|---|
001 (N/A) | M | 27 | 166 | 60 | 220 |
002 (lung) | F | 57 | 166 | 61 | 242 |
003 (lung) | M | 28 | 174 | 75 | 302 |
004 (N/A) | M | 31 | 170 | 72 | 289 |
005 (liver) | M | 47 | 178 | 105 | 387 |
006 (N/A) | F | 35 | 164 | 63 | 233 |
007 (N/A) | F | 30 | 162 | 73 | 294 |
008 (gastrointestinal) | M | 24 | 182 | 99 | 366 |
009 (N/A) | M | 57 | 175 | 73 | 278 |
010 (lung) | F | 49 | 165 | 75 | 301 |
011 (N/A) | M | 55 | 173 | 80 | 218 |
012 (N/A) | F | 58 | 168 | 60 | 261 |
Mean ± s.d | 7 M, 5F | 41.5 ± 12.9 | 170.2 ± 5.9 | 74.6 ± 14.4 | 282.5 ± 53.4 |